More about
Extensive Actinic Keratosis
News
June 10, 2024
1 min read
Save
FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas
The FDA has approved the expanded use area of Klisyri to up to 100 cm2 on the face and scalp for the treatment of actinic keratosis, Almirall announced in a press release.